Feinsod Matthew Insider Trades

Insider Trading History

Track insider trading activity for Feinsod Matthew. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kalaris Therapeutics
Kalaris Therapeutics KLRS
Chief Medical Officer
Holding Value $629k 135,000 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$919k 135,000 shares
$6.81
$4.66
Kalaris Therapeutics
Kalaris Therapeutics KLRS
Chief Medical Officer
Holding Value $471k 101,000 shares
Last Trade
Apr 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$4.66
Kalaris Therapeutics
Kalaris Therapeutics KLRS
Chief Medical Officer
Holding Value $132k 28,224 shares
Last Trade
Mar 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$4.66
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Exec. Vp, Global Strat. & Dev.
Holding Value $39.4k 100,000 shares
Last Trade
Jul 29, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$391k 100,000 shares
$3.91
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $22.1k 56,052 shares
Last Trade
Jul 11, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.22k 592 shares
$3.75
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $22.3k 56,644 shares
Last Trade
Jul 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.5k 2,000 shares
$3.75
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $21.5k 54,644 shares
Last Trade
Jun 11, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.58k 685 shares
$3.77
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $21.8k 55,329 shares
Last Trade
Jun 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.4k 2,000 shares
$3.70
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $21.5k 54,644 shares
Last Trade
Jun 11, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.53k 685 shares
$3.70
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $21k 53,329 shares
Last Trade
May 13, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.88k 685 shares
$4.20
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $21.3k 54,014 shares
Last Trade
May 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.12k 2,000 shares
$4.06
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $21k 53,329 shares
Last Trade
May 13, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.78k 685 shares
$4.06
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $20.7k 52,620 shares
Last Trade
Apr 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.22k 2,000 shares
$4.61
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $20.5k 52,014 shares
Last Trade
Apr 11, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.79k 606 shares
$4.61
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $20.2k 51,287 shares
Last Trade
Mar 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.94k 2,000 shares
$3.97
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $19.9k 50,620 shares
Last Trade
Mar 11, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.65k 667 shares
$3.97
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $19.4k 49,287 shares
Last Trade
Feb 11, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.6k 791 shares
$3.29
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $19.7k 50,078 shares
Last Trade
Feb 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.58k 2,000 shares
$3.29
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $18.9k 48,078 shares
Last Trade
Jan 11, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.28k 713 shares
$3.20
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Interim Chief Medical Officer
Holding Value $19.2k 48,791 shares
Last Trade
Jan 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.4k 2,000 shares
$3.20
$0.39

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up